Oxford Asset Management’s AdaptHealth AHCO Stock Holding History

Oxford Asset Management’s Portfolio AHCO Stock Details AHCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-32,056	Closed	-$234K	–	261
2023 Q4	$234K	Buy	+32,056	New	+$253K	0.35%	120

Other funds holding AHCO

OCA

OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Oxford Asset Management's AHCO Position: Q1 2024 in Review

Oxford Asset Management sold out of AdaptHealth (AHCO) in Q1 2024, closing a stake of 32,056 shares — an estimated $234K sold.

Oxford Asset Management first reported a position in AHCO in Q4 2023 and held it in 1 quarter. The position peaked at $234K in Q4 2023. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

Oxford Asset Management reported no remaining AdaptHealth position as of Q1 2024 after selling out during the quarter.
Oxford Asset Management sold 32,056 AdaptHealth shares in Q1 2024, an estimated $234K.
Oxford Asset Management first reported a position in AdaptHealth in Q4 2023 and held it in 1 quarter.
Oxford Asset Management's AdaptHealth position peaked at $234K in Q4 2023.
210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Oxford Asset Management's 13F filing for Q1 2024, filed 15 May 2024.